Overview A veterinary biologic for the treatment of mixed mammary tumor and mammary adenocarcinoma in dogs.

  • An emulsion of mycobacterium cell wall fractions which have been modified to reduce their toxic and allergic effect but retain their antitumor activity
  • Safely treats canine mammary cancer alone or in combination with surgery
  • Administered by intratumoral injection, with a generalized response where untreated sites frequently undergo regression as well
  • High tumor-free survival rate
  • A treatment option for dogs that are poor surgical risks
  • Minimizes side effects associated with chemotherapeutic treatments
  • May be used safely in-clinic with no risk to clinic personnel
  • An economical treatment option for your clients
  • Excellent safety profile for the patient